A multi-center study that validates the clinical performance of IsoPSA—a new blood test that has proven to be more accurate
Continue reading »
Could wearable tech address issues caused by overcrowding in emergency departments?
It isn’t surprising that when hospital emergency departments become overcrowded, care becomes more fragmented, but a recent study by University
Continue reading »Could nonprofit drug companies cut sky-high prices?
(HealthDay)—Generic prescription drugs should be cheap, but prices for some have soared in the United States in recent years. Now
Continue reading »Six months of Herceptin could be as effective as 12 months for some women with HER2 positive breast cancer
For women with HER2 positive early-stage breast cancer taking Herceptin for six months could be as effective as 12 months
Continue reading »New rabies test could radically change testing, treatment
(HealthDay)—A new rapid rabies test for animals could revolutionize screening and spare humans unnecessary painful treatment, according to a U.S.
Continue reading »Identifying PTSD could be affected under proposed changes to global diagnostic tool
Fewer individuals across the globe would be diagnosed with post-traumatic stress disorder (PTSD) under proposed changes to the most widely
Continue reading »How understanding pain could curb opioid addiction
The Senate Health, Education, Labor and Pensions Committee unanimously approved a bill in April 2018 designed to address the opioid
Continue reading »Metastasis enablers: Findings could unlock new ovarian cancer treatments
In order to spread their destruction, ovarian cancer cells must break free from their tumor home, travel through the fluid
Continue reading »A new machine learning tool could flag dangerous bacteria before they cause an outbreak
A new machine learning tool that can detect whether emerging strains of the bacterium, Salmonella are more likely to cause
Continue reading »Blood test could offer life-and-death clues for African-American diabetics
Testing blood for a biological marker called suPAR could help better assess the risk of death among African-Americans with Type
Continue reading »